Status:
UNKNOWN
HOme USability Evaluation
Lead Sponsor:
Entia Ltd
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To validate the usability and safety of the Liberty Analyser.
Eligibility Criteria
Inclusion
- Undergoing systemic anti-cancer therapy (SACT)
- Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment
- Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser
- Patients capable of providing written informed consent
Exclusion
- History or current diagnosis of haematological malignancy
- Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training
- Inadequate use and understanding of the English language, requiring a translator
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06134245
Start Date
March 1 2024
End Date
June 30 2024
Last Update
November 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.